In this panel discussion Bhavna Kewalramani, Allegra Lead, South Asia, Sanofi India, and Atul Suri, senior vice president, SBU head, Alembic Pharmaceuticals, decode strategies and challenges in influencing decision-makers, focusing on science and evidence-based research.

The duo tapped into government regulation, patient-centricity, and the need for industry collaboration and advocacy.

Praful Akali, founder and managing director, Medulla Communications, was moderating the panel which also accentuated the importance of awareness campaigns for both patients and doctors.

View the panel discussion above.